Therapeutic Drug Monitoring (TDM) of Cyclosporine Using the Area Under the Curve in Children Undergoing Hematopoietic Stem Cell Transplant (HSCT)

被引:1
|
作者
Therrien, Roxane [1 ]
Tourel, Julien [1 ]
Sid-Otmane, Lamia [1 ]
Duval, Michel [1 ]
机构
[1] CHU Ste Justine, Montreal, PQ, Canada
关键词
D O I
10.1016/j.bbmt.2012.11.616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
551
引用
收藏
页码:S379 / S379
页数:1
相关论文
共 50 条
  • [1] The importance of Therapeutic Drug Monitoring (TDM) for parenteral busulfan dosing in conditioning regimen for Hematopoietic Stem Cell Transplantation (HSCT) in children
    Tesfaye, Hndie
    Branova, Romana
    Klapkova, Eva
    Prusa, Richard
    Janeckova, Daniela
    Riha, Petr
    Sedlacek, Petr
    Keslova, Petra
    Malis, Josef
    [J]. ANNALS OF TRANSPLANTATION, 2014, 19 : 214 - 224
  • [2] Prediction of Area under the Cyclosporine Concentration Versus Time Curve in Children Undergoing Hematopoietic Stem Cell Transplantation
    Dupuis, L. Lee
    Seto, Winnie
    Teuffel, Oliver
    Gibson, Paul
    Schultz, Kirk R.
    Doyle, John D.
    Gassas, Adam
    Egeler, R. Maarten
    Sung, Lillian
    Schechter, Tal
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (03) : 418 - 423
  • [3] CYCLOSPORINE AREA UNDER THE CURVE (AUC) IN CHILDREN UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT): LIMITED SAMPLING STRATEGY (LSS)
    Schechter, T.
    Teuffel, O.
    Gibson, P.
    Sung, L.
    Seto, W.
    Gassas, A.
    Doyle, J.
    Dupuis, L. L.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S258 - S259
  • [4] REITERATED THERAPEUTIC DRUG MONITORING (TDM) TO BETTER CONTROL TARGETED EXPOSURE TO IV BUSULFAN IN INFANTS AND OLDER CHILDREN UNDERGOING HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT)
    Bourget, P.
    Neven, B.
    Amin, A.
    Chomton, M.
    Cros, G.
    Elkaim, E.
    Fremond, M. -L.
    Moshous, D.
    Touzot, F.
    Ader, F.
    Lalli, A.
    Petain, A.
    Nguyen, L.
    Blanche, S.
    [J]. HAEMATOLOGICA, 2015, 100 : 281 - 281
  • [5] Reiterated Therapeutic Drug Monitoring (TDM) Dosing to Significantly Improve the Control of Exposure to IV Busulfan in Infants and Older Children Undergoing Hematopoietic Stem-Cell Transplantation (HSCT)
    Amin, Alexandre
    Bourget, Philippe
    Neven, Benedicte
    Fremond, Marie-Louise
    Castelle, Martin
    Elkaim, Elodie
    Cros, Guilhem
    Moshous, Despina
    Touzot, Fabien
    Lalli, Alexandre
    Petain, Aurelie
    Nguyen, Laurent
    Blanche, Stephane
    [J]. BLOOD, 2015, 126 (23)
  • [6] HIGHLY VARIABLE PLASMA CONCENTRATIONS OF VORICONAZOLE IN CHILDREN UNDERGOING HSCT: THERAPEUTIC DRUG MONITORING (TDM) IS INDISPENSABLE
    Bierings, M. B.
    Wolfs, T.
    Tessa, V
    Jaap, B. J.
    Imke, B.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S228 - S229
  • [7] BONE Loss in Patients Undergoing Hematopoietic STEM CELL Transplant (HSCT)
    Kotwal, Narendra
    Pandit, Aditi Dilip
    Garg, M. K.
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)
  • [8] Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: Limited sampling strategies
    Sibbald, Cathryn
    Seto, Winnie
    Taylor, Tracey
    Saunders, E. Fred
    Doyle, John
    Dupuis, L. Lee
    [J]. THERAPEUTIC DRUG MONITORING, 2008, 30 (04) : 434 - 438
  • [9] Evaluation of Cyclosporine Pharmacokinetic, Monitoring, and Dosing Parameters for GVHD Prophylaxis in Hematopoietic Stem Cell Transplant (HSCT) Recipients
    Tafazoli, Ali
    Dadashzadeh, Simin
    Mehdizadeh, Mahshid
    Parkhideh, Sayeh
    Tavakoli-Ardakani, Maria
    [J]. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 : 302 - 314
  • [10] Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients
    Trifilio, S
    Ortiz, R
    Pennick, G
    Verma, A
    Pi, J
    Stosor, V
    Zembower, T
    Mehta, J
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 (05) : 509 - 513